Berlin / Prague / Oslo / London / Brussels / Venice / /
Company
EC / /
Continent
Europe / /
Country
Norway / Belgium / Italy / Portugal / United Kingdom / Czech Republic / /
Currency
EUR / / /
IndustryTerm
pharmaceuticals / treatment of Alzheimer’s disease / health systems / pharmaceutical products / pharmaceutical policy / pharmaceutical and medical devices / /
Organization
Science and Technology Advisory Council / Congress / 3rd EBC Board / 1st EBC Industry Board / European Medicines Agency / Barroso's Science and Technology Advisory Council / European Commission / EU Commission / European Public Health Alliance / Enterprise Directorate / European Association of Research and Technology Organisations / European Union / Federation of European Neuroscience Societies / 1st EBC Board / European Parliament / Commission’s Health and Consumer Directorate / 3rd Industry Board / 2nd EBC Board / Society for Neuroscience / 2nd Industry Board / /
YOUR AGENDA Official / Economist / Industry Commissioner / President / senior official / Health Commissioner / EurActiv France reports / Secretaries-General / President of the EP S&D group / head / /
Week of 13 October 2014 QUOTE OF THE WEEK A new shared competence for medicines and medical devices [will be divided] between the directorates for health and consumer affairs (DG SANCO), and enterprise and industry (DG E